SCHEMBL9108512

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL9105717	0.87	PLA2G7 (0.41)	PLA2G7CYP1A2CYP3A4TSHRCYP2C9
	SCHEMBL9108584	0.85	PLA2G7 (0.45)	PLA2G7
	SCHEMBL9105930	0.85	FABP4 (0.38)	PLA2G7ALDH1A1
	SCHEMBL9109999	0.85	CNR2 (0.40)	PLA2G7
	SCHEMBL9107465	0.84	PLA2G7 (0.51)	PLA2G7
	SCHEMBL9105082	0.84	PLA2G7 (0.41)	PLA2G7CYP1A2CYP3A4TSHRCYP2C9
	SCHEMBL9105663	0.83	DAO (0.40)	ALDH1A1HPGD
	SCHEMBL9106511	0.82	PLA2G7 (0.49)	PLA2G7
	SCHEMBL9108265	0.81	PLA2G7 (0.42)	PLA2G7
	SCHEMBL9105533	0.81	PARP1 (0.36)	PLA2G7CYP2C9GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.